Type 2 diabetes
Conditions
Interventions
Single administration of canagliflo zin and wash out and single administration of tofogliflozin
Single administration of tofogliflozin and wash out and single administration of canagliflozin
Sponsors
St Marianna University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)The inpatients with type 2 diabetes,2)Patients who are capable of making a decision by themselves, and can provide written consent
Exclusion criteria
Exclusion criteria: 1)Type 1 diabetes,2)Patients whose blood glucose level is less than 100 mg /dL on under insulin or sulfonylurea treatment, 3)Patients with postvoid residual urine of benign prostatic hyperplasia and neurogenic bladder,4)eGFR<30mL/min/1.73m2,5)Women who were pregnant, possibly pregnant, or were breast-feeding,6)Genital infection or urinary tract infection,7)Being treated diuretics,8)Insulin-dependent type 2 diabetes,9)Other patients who were considered to be ineligible for the study by the attending doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total area under the glucose concentration curve for 3 hours after breakfast obtained from CGM | — |
Secondary
| Measure | Time frame |
|---|---|
| 3 hours and 24 hours postprandial urinary glucose | — |
Countries
Japan
Contacts
Public ContactSatoshi Ishii
St Marianna University School of Medicine Division of Metabolism and Endocrinology,Depertment of Internal Med icine
Outcome results
None listed